ResMed Reports Earnings/Stock Split (RMD)

ResMed Inc. (NYSE: RMD) reports Q2 earnings of $0.68 versus estimates of $0.66. ResMed Inc. reports Q2 revenues of $291.6 million versus estimates of $293.81 million.

Revenues increased 16% year over year (18% on a constant currency basis).

ResMed Inc. also announced today that its board of directors approved a two-for-one stock split of the company's outstanding shares of common stock, payable in the form of a 100% stock dividend.

Kieran T. Gallahue, President and Chief Executive Officer, commented, "In the fourth quarter of fiscal 2010, we continued to show strong growth year-over-year in the Americas, as well as in international markets. Our favorable mix of product sales and market share gains led to a 20% revenue increase in the Americas over the prior year's quarter, resulting in $160.9 million in sales. Revenue outside the Americas increased by 11% to $130.7 million over the prior year's quarter, or a 16% increase on a constant currency basis.”

He added, “Globally, our growth in flow generators was mainly driven by strong sales of the new S9(TM) AutoSet and Elite products. Mask sales were particularly robust this quarter across all categories and across all geographies. Operating profit for the June quarter was $68.6 million and cash flow from operations was $59.0 million, demonstrating excellent operating performance.”

Shares of RMD are flat in the after-hours trade.